Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $12.5752W HIGH $26.56
Volume
3.06 K
Value Traded
4.29 M
Short % Float
6.91%
-1.08%Week
-3.04%1 Month
-33.3%3 Month
-19.05%6 Month
-81.85%5 Year
+2,825.27%All Time
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
271.51 M
EPS (TTM)
-1.20
P/E Ratio
-
Ent. Value
102.31 M
Total Shares
18.47 M
Float Shares
10.92 M
Insiders
40.90%
Institutions
61.85%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
USNA Catalyst Timeline
Dated clinical, regulatory and corporate events for USANA Health Sciences, Inc.
Catalyst Timeline
Dated clinical, regulatory & corporate events for USANA Health Sciences, Inc.
78Total events
0Upcoming
4Tier-1 (high impact)
2017 to 2026Coverage
Event history 50
▲Partnership / LicenseCorporate
USANA and University of Utah Athletics announce new partnership
▼Quarterly UpdateCorporate
USANA updates FY2024 net sales outlook to $850-$880M and EPS to $2.40-$2.55
●Quarterly UpdateCorporate
Company reiterates FY2024 net sales outlook of $850M-$920M and diluted EPS of $2.40-$3.00
●Quarterly UpdateCorporate
USANA provides initial FY2024 net sales guidance of $850M-$920M and diluted EPS guidance of $2.40-$3.00
▲Other Regulator MilestoneEx-US Regulatory
USANA plans to open 25th global market in India, commence operations in late 2023
▲Other Regulator MilestoneEx-US Regulatory
USANA finalizes plans to commence operations in India, anticipates opening prior to year-end 2023
◆Management ChangeCorporate
Kevin Guest to transition to Executive Chairman, Jim Brown to become CEO
●Quarterly UpdateCorporate
USANA reiterates FY2022 net sales outlook of $1.015B-$1.065B and diluted EPS of $3.85-$4.45
●Quarterly UpdateCorporate
USANA provides initial fiscal 2022 net sales guidance of $1.125-$1.225 billion and diluted EPS guidance of $5.25-$6.00
●Quarterly UpdateCorporate
USANA reports Q3 2021 net sales of $274.4M and diluted EPS of $1.36
●Quarterly UpdateCorporate
USANA increased share repurchase authorization on September 16, 2021
●Quarterly UpdateCorporate
Reiterates FY2021 net sales outlook of $1.24-$1.28B and diluted EPS of $6.15-$6.50
▲Quarterly UpdateCorporate
USANA reports Q1 2021 net sales of $308.0M and diluted EPS of $1.45
▲Product LaunchPost-Market
Launch of Active Nutrition line in select markets
weight management, digestive health, energy, hydrationsource ↗
●Quarterly UpdateCorporate
USANA expects to generate approximately $130M of free cash flow in fiscal 2021
Past FDA Catalysts and PDUFA Decisions
How USNA actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
USANA Health Sciences, Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every USNA program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Armstrong Kathryn MichelleOfficer (CHIEF SCIENTIFIC OFFICER) | Option | 1,166 3,989 held | $0.00 | 07/25/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in USNA
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in USNA for Q2 2026. | ||||
USNA Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How USNA ranks across every disease it competes in
Competitive Position is a premium feature
See how USNA ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialUSNA News
USNA▲ +0.8%today
USANA Health Sciences and University of Utah Athletics Announce New Partnership
USANA Health Sciences has partnered with the University of Utah Athletics to support over 500 student-athletes across 19 sports. The partnership aims to enhance athlete health and performance through access to nutritional products and community initiatives. USANA's founder has ties to the university, adding significance to the collaboration.
Read more →USNAUSANA CEO Kevin Guest Shares Three Ways to Celebrate International Music Day
On International Music Day, USANA CEO Kevin Guest encourages people to embrace music as a means to reduce stress and foster connections. He shares personal anecdotes about music's impact on his life and suggests ways to celebrate the day, including exploring new musical genres and sharing songs with others. Research supports the emotional and social benefits of engaging with music.
Read more →USNAUSANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then Act
USANA CEO Kevin Guest urges individuals to incorporate service into their daily lives, emphasizing the importance of listening and acting on opportunities to help others. He outlines three actionable steps to implement The Holland Principle, which he developed during his missionary service. Guest also highlights USANA's humanitarian efforts, including delivering over 120 million meals through the USANA Foundation.
Read more →USNA▼ -34.2%on this news
USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August
Kevin Guest, CEO of USANA Health Sciences, emphasizes the importance of creating happiness in both personal and professional settings during Happiness Happens Month. He shares five actionable strategies to cultivate joy, including practicing gratitude, recognizing others, and prioritizing meaningful relationships. Guest's insights are drawn from his book, which also supports feeding hungry children.
Read more →USNA▼ -34.2%on this newsshared move
USANA Health Sciences Reports Second Quarter 2026 Results
USANA Health Sciences reported a challenging second quarter for 2026, with net sales declining to $223 million from $236 million in the same period last year. The company experienced a net loss of $(21.4) million, which included a non-cash impairment charge of $29.1 million. This contrasts sharply with the previous year's net earnings of $9.7 million, resulting in a diluted EPS of $(1.16).
Read more →USNANew 12-Week Consumer Study Highlights Visible Skin Benefits with USANA Glow
USANA Health Sciences announced positive results from a 12-week consumer study of its skincare supplement, Glow. The study involved 36 participants from the U.S. and Mexico, with 97.2% reporting improvements in skin brightness, tone, and radiance. The product aims to enhance skin health from within, supported by a science-backed formula.
Read more →USNAUSANA Health Sciences Renews Four-Year Partnership with Nordiq Canada, Deepening Commitment to Clean Sport and Elite Athlete Nutrition
USANA Health Sciences has renewed its partnership with Nordiq Canada, continuing its role as the official nutrition partner for Canada's elite cross-country ski athletes through 2030. The agreement emphasizes a commitment to clean sport and athlete health, providing NSF Certified for Sport nutritional products. This partnership reflects USANA's dedication to supporting athletes' performance and integrity.
Read more →USNAUSANA Schedules Second Quarter 2026 Earnings Release and Conference Call
USANA Health Sciences, Inc. has announced the release of its second quarter 2026 earnings results, which will be available after market close on August 4, 2026. Following the earnings release, a Management Commentary document will be posted on the company's Investor Relations website. Additionally, a conference call will be held to discuss the results with analysts.
Read more →USNAKevin Guest: World Cup Determination Shows the Power of Grit, Preparation, Persistence
Kevin Guest, CEO of USANA Health Sciences, draws parallels between World Cup athletes and personal success in his book, 'All the Right Reasons.' He emphasizes the importance of grit, discipline, and persistence in achieving goals. Guest outlines five actionable steps to apply The Piano Principle in life, highlighting the necessity of commitment and daily effort to realize one's dreams.
Read more →USNAUSANA Celebrates 10 Years of Making the World a Better Place During World Service Week
USANA marks 10 years of World Service Week, uniting its community for acts of kindness. This year, they aim to feed 20,000 families through donations. Activities include supporting vulnerable children, community enrichment, and educational empowerment. The USANA Foundation has significantly impacted lives globally with its sustainable food initiatives.
Read more →USNAUSANA's Celavive Contouring Face & Neck Crème Named Among Canada's Top Skincare Products
USANA Health Sciences announced that its Celavive Contouring Face & Neck Crème has been awarded the title of Best Neck & Décolleté Cream by The Beauty Awards Canada. This recognition underscores the product's innovative formulation and effectiveness in skincare. The award highlights USANA's dedication to quality and performance in the beauty industry.
Read more →USNAUSANA Earns Dual Best of State Honors for Product Innovation and Development
USANA has been awarded two Best of State honors in Salt Lake City, recognizing its CellSentials supplements and Research and Development team. This marks the tenth consecutive year for CellSentials and the eighth win for the R&D team. The awards highlight USANA's commitment to scientific rigor and product quality.
Read more →USNAKevin Guest Encourages Professionals to Prioritize Wellness During Professional Wellness Month
Kevin Guest, CEO of USANA Health Sciences, advocates for prioritizing wellness during Professional Wellness Month. He emphasizes that healthy habits enhance productivity and workplace culture. Guest encourages individuals to adopt simple daily practices, such as consistent sleep and building relationships, to improve both personal and professional well-being. He believes that recognizing individual contributions is essential for a thriving work environment.
Read more →USNAUSANA's People-First Culture Earns Spot on USA TODAY Top Workplaces List
USANA Health Sciences has been named one of the 2026 USA TODAY Top Workplaces, recognizing its commitment to a people-first culture. The award highlights USANA's strong employee benefits, including onsite health amenities and tuition reimbursement. This recognition is based on authentic employee feedback, showcasing the company's dedication to fostering a supportive workplace environment.
Read more →USNAUSANA Health Sciences Reports First Quarter 2026 Results Company Continues to Make Significant Progress on Transformation to Becoming a Leading Omnichannel Health and Wellness Platform
USANA Health Sciences has released its financial results for the first quarter of 2026, reporting net sales of $250 million, unchanged from the previous year. However, the company experienced a decline in net earnings and diluted EPS, reflecting a shift in its business model towards an omnichannel strategy. Active customer numbers in the Core Nutritional segment fell, while other segments like Rise Wellness showed strong growth. Despite the overall mixed performance, USANA reiterated its fiscal guidance for 2026.
Read more →USNAUSANA Health Sciences Reports First Quarter 2026 Results
USANA Health Sciences has released its financial results for the first quarter of 2026. The report includes key performance metrics and insights into the company's operations. However, specific details regarding revenue, profit margins, or strategic initiatives were not provided in the article.
Read more →USNADuring National Show Your Smile Month, Kevin Guest Urges Leaders to Lift Others Daily
During National Show Your Smile Month, Kevin Guest, CEO of USANA Health Sciences, emphasizes the importance of smiling in leadership and personal interactions. He asserts that a genuine smile can lower stress, build trust, and enhance communication. Guest encourages individuals to incorporate smiling into their daily routines to foster better relationships and improve overall well-being.
Read more →USNAOne Capsule, Endless Glow--Radiant Skin Starts Within
USANA Health Sciences has launched Glow, its first skin supplement aimed at enhancing skin health from within. This innovative product features clinically studied ingredients designed to improve skin clarity, support collagen production, and protect against environmental stress. Clinical trials indicate significant improvements in skin radiance and uniformity among participants. Glow represents a shift towards internal solutions for skincare.
Read more →USNAUSANA Schedules First Quarter 2026 Earnings Release and Conference Call
USANA has announced the scheduling of its earnings release for the first quarter of 2026, along with a conference call. Specific details regarding the time and date of the call have not been provided. This event is part of USANA's regular financial reporting process.
Read more →USNAUSANA CEO Kevin Guest Calls for Daily Health Routines on World Health Day
On World Health Day, USANA CEO Kevin Guest advocates for a shift from awareness to execution in health routines. He emphasizes the importance of daily habits and personal accountability over mere knowledge. Guest argues that consistent actions, rather than intense but short-lived efforts, lead to lasting health improvements. His insights are aligned with principles from his book, promoting clarity of purpose and community support.
Read more →About USANA Health Sciences, Inc.
Headquarters3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT, 84120-6336
BIOPHARMAWATCH ELITE PLUS
Trade the next USNA catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime